NOT KNOWN DETAILS ABOUT TIRZEPATIDE

Semaglutide has long been shown to lead to medullary thyroid cell carcinoma in rodents. Whilst its medical relevance to humans is not known, the FDA advises not to administer this drug in All those with a personal or household heritage of medullary thyroid carcinoma. Semaglutide also poses a risk of pancreatitis and dehydration.para reducir el ries